Atrioventricular (AV) reentrant tachycardia is a common type of supraventricular tachycardia (SVT) that occurs in the fetus and neonate. Although many tachycardias resolve within several weeks of birth or respond to medical management, disruptions in the cardiac annulus fibrosus and development of additional accessory pathways may lead to refractory dysrhythmia resulting in fetal hydrops and ultimately, fetal death.
Objectives:
While accessory pathways have been well documented anatomically in adult and childhood tachyarrhythmias, there are no reports of the histology of these pathways in human fetuses with SVT.
Research Design, Subjects, Measures:
This is a small case series of 2 fetuses with a history of SVT that resulted in fetal hydrops.
Results:
In both cases, examination of the cardiac conduction system was unremarkable and examination of the atrioventricular junction revealed a focally thinned and/or discontinuous annulus fibrosus with documented direct continuity between the atrial and ventricular myocardium in 1 case.
Conclusions:
This case series demonstrates that thinning or absence of the annulus fibrosus is a feature seen in fetal SVT, and the development of subsequent aberrant AV connections due to defective formation of the annulus fibrosus suggests a possible cause for these arrhythmias.
KnightBP (2021). Anatomy, pathophysiology, and localization of accessory pathways in the preexcitation syndrome. UpToDate. Accessed May 18, 2019. www.uptodate.com
2.
Di BiaseLWalshEP (2022). Wolff-Parkinson-White syndrome: anatomy, epidemiology, clinical manifestations, and diagnosis. UpToDate. Accessed May 18, 2019. www.uptodate.com
3.
PodridPJ (2022). Lown-Ganong-Levine syndrome and enhanced atrioventricular nodal conduction. UpToDate. Accessed June 13, 2019. www.uptodate.com
MarinoTAKaneBM. Cardiac atrioventricular junctional tissues in hearts from infants who died suddenly. J Am Coll Cardiol. 1985;5:1178-1184.
7.
SealyWC. His bundle interruption for reentry tachycardia in Wolff-Parkinson-White syndrome. Ann Thorac Surg. 1983;36:345-352.
8.
LevMFoxSMBharatiSGreenfieldJCRosenKMPickA. Mahaim and James fibers as a basis for a unique variety of ventricular preexcitation. Am J Cardiol. 1975;36:880-888.
9.
TruexRCBishofJKHoffmanEL. Accessory atrioventricular muscle bundles of the developing human heart. Anat Rec. 1958;131:45-59.
10.
HoSY. Accessory atrioventricular pathways: getting to the origins. Circulation. 2008;117:1502-1504.
11.
LevineJCAlexanderME. Fetal arrhythmias. UpToDate. Accessed May 8, 2019. www.uptodate.com
KoJKDealBJStrasburgerJFBensonDW. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol. 1992;69:1028-1032.
15.
NaheedZJStrasburgerJFDealBJBensonDWGiddingSS. Fetal tachycardia: mechanisms and predictors of hydrops fetalis. J Am Coll Cardiol. 1996;27:1736-1740.
16.
SimpsonJMSharlandGK. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart. 1998;79:576-581.
17.
Frohn-MulderIMStewartPAWitsenburgMden HollanderNSWladimiroffJWHessJ. The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia. Prenat Diagn. 1995;15:1297-1302.
18.
Ekman-JoelssonBMMellanderMLagnefeldtLSonessonSE. Foetal tachyarrhythmia treatment remains challenging even if the vast majority of cases have a favourable outcome. Acta Paediatr. 2015;104:1090-1097.
19.
AanhaanenWTBoukensBJSizarovA, et al. Defective Tbx-2-dependent patterning of the atrioventricular canal myocardium causes accessory pathway formation in mice. J Clin Invest. 2011;121(2):534-544.
20.
LockhartMMPhelpsALvan den HoffMJBWesselsA. The epicardium and the development of the atrioventricular junction in the murine heart. J Dev Biol. 2014;2(1):1-17.
21.
HahurijNDKolditzDPBokenkampR, et al. Accessory atrioventricular myocardial pathways in mouse heart development: substrate for supraventricular tachycardias. Pediatr Res. 2011;70:37-43.
22.
BeckerAEAndersonRHDurrerDWellensHJ. The anatomical substrates of Wolff-Parkinson-White syndrome. A clinicopathologic correlation in seven patients. Circulation. 1978;57(5):870-879.
23.
WesselsAMarkmanMWMVermeulenJLMAndersonRHMoormanAFMLamersWH. The development of the atrioventricular junction in the human heart. Circ Res. 1996;78:110-117.
24.
JensenBBoukensBJDPostmaAV, et al. Identifying the evolutionary building blocks of the cardiac conduction system. PLoS One. 2012;7(9):e44231.
25.
van WeerdJHChristoffelsVM. The formation and function of the cardiac conduction system. Development. 2016;143:197-210.
26.
AanhaanenWTJMoormanAFMChristoffelsVM. Origin and development of the atrioventricular myocardial lineage: insight into the development of accessory pathways. Birth Defects Res A Clin Mol Teratol. 2011;91:565-577.
27.
OttavianiGBujaLM. Anatomopathological changes of the cardiac conduction system in sudden cardiac death, particularly in infants: advances over the last 25 years. Cardiovasc Pathol. 2016;25:489-499.
28.
OttavianiGMatturriL. Histopathology of the cardiac conduction system in sudden intrauterine unexplained death. Cardiovasc Pathol. 2008;17:146-155.
29.
MatturriLOttavianiGRamosSGRossiL. Sudden infant death syndrome (SIDS): a study of cardiac conduction system. Cardiovasc Pathol. 2000;9:137-145.
30.
JamesTN. Sudden death in babies: new observations in the heart. Am J Cardiol. 1968;22:479-506.
31.
HahurijNDGittenberger-De GrootACKolditzDP, et al. Accessory atrioventricular myocardial connections in the developing human heart: relevance for perinatal supraventricular tachycardias. Circulation. 2008;117:2850-2858.
32.
TempleIPInadaSDobrzynskiHBoyettMR. Connexins and the atrioventricular node. Heart Rhythm. 2013;10:297-304.
33.
AhirBPrattenMK. Structure and function of gap junction proteins: role of gap junction proteins in embryonic heart development. Int J Dev Biol. 2014;58:649-662.
34.
ErnstLMFritschMK. Heart. In: ErnstLMRuchelliEDCarreonCKHuffDS, eds. Color Atlas of Human Fetal and Neonatal Histology. 2nd ed.Springer; 2019:3-19.
35.
LandryNMCohenSDixonIMC. Periostin in cardiovascular disease and development: a tale of two distinct roles. Basic Res Cardiol. 2017;113(1):1.
36.
DobrzynskiHAndersonRHAtkinsonA, et al. Structure, function and clinical relevance of the cardiac conduction system, including the atrioventricular ring and outflow tract tissues. Pharmacol Ther. 2013;139:260-288.
37.
YamaneKTakahashiYFujiiH, et al. Histology of the tricuspid valve annulus and right atrioventricular muscle distance. Interact Cardiovasc Thorac Surg. 2022;35(2):ivac175.
38.
LockhartMMBoukensBJDPhelpsAL, et al. Alk3 mediated Bmp signaling controls the contribution of epicardially derived cells to the tissues of the atrioventricular junction. Dev Biol. 2014;396(1):8-18.
39.
ChristoffelsVMMoormanAFM. Development of the cardiac conduction system: why are some regions of the heart more arrhythmogenic than others?Circ Arrhythm Electrophysiol. 2009;2:195-207.
40.
MoodleySSanataniSPottsJESandorGGS. Postnatal outcome in patients with fetal tachycardia. Pediatr Cardiol. 2013;34:81-87.
41.
KrappMKohlTSimpsonJMSharlandGKKatalinicAGembruchU. Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart. 2003;89:913-917.
42.
KarmegerajBNamdeoSSudhakarAKrishnanVKunjukuttyRVaidyanathanB. Clinical presentation, management, and postnatal outcomes of fetal tachyarrhythmias: a 10-year single-center experience. Ann Pediatr Cardiol. 2018;11(1):34-39.
43.
KrappMBaschatAAGembruchUGeipelAGermerU. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia. Ultrasound Obstet Gynecol. 2002;19:158-164.
Azancot-BenistyAJacqz-AigrainEGuirgisNMDecrepyAOuryJFBlotP. Clinical and pharmacologic study of fetal supraventricular tachyarrhythmias. J Pediatr. 1992;121:608-613.
46.
HansmannMGembruchUBaldRManzMRedelDA. Fetal tachyarrhythmias: transplacental and direct treatment of the fetus – a report of 60 cases. Ultrasound Obstet Gynecol. 1991;1:162-168.
